Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 57%
Hold 14%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services Inc. reported second-quarter revenue of $658.2 million, representing a decrease of 11% year-over-year, but still exceeding estimates of $647.1 million and consensus expectations of $652.1 million. The company achieved a gross margin of 29.8%, which marked a sequential increase of 120 basis points, surpassing its guidance range of 28.5-29.0%. Furthermore, AMN demonstrated strong operational efficiency with an EBITDA of $58.3 million, which exceeded both internal estimates and consensus forecasts, highlighting an average revenue surprise of 3% and an average EBITDA surprise of 12% over the past four quarters.

Bears say

AMN Healthcare Services Inc. reported a decline in segment revenue across its major divisions, with nurse and allied solutions dropping by 9% year-over-year and physician and leadership solutions experiencing a 14% decrease. This reduction in revenue is compounded by a contraction in operating margins, with the nurse and allied solutions segment’s gross margin decreasing by 40 basis points sequentially, and an overall decline in VMS revenue of 31% year-over-year. Additionally, the average number of travelers on assignment decreased by 3% quarter-over-quarter, indicating potential challenges in sustaining workforce levels that can further impact revenue generation in the future.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.07, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.07, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.